Peter Ashley Marks
CIK: 0002127888
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATHE
ALTERITY THERAPEUTICS LTD
Director
Discretionary Trading P&L
Holdings
About Marks Peter Ashley
Marks Peter Ashley (SEC CIK 0002127888) files insider reports with the SEC as Director of ALTERITY THERAPEUTICS LTD (ATHE).
Signal8 holds 2 ownership filings by Marks Peter Ashley (1 Form 3, 1 Form 4), filed between Apr 10, 2026 and Sep 8, 2026. Those filings report 1 transaction, the latest on Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Marks Peter Ashley's filings is in MELBOURNE.
Recent filings by Marks Peter Ashley
- Aug 31, 2026: Open-market purchase of ATHE shares (Form 4, code P).
Other insiders filing for ALTERITY THERAPEUTICS LTD (ATHE)
- Stamler David Allen, Chief Executive Officer
- Babarczy Julian Michael, Director
- Gozlan Lawrence Bernard, Director
- Cunningham Ann Michelle, Director
- Macnish Niven Abby Sarah, Chief Financial Officer